Pharmacist-led interventions may prevent heart disease | WeForNews | Latest News, Blogs Pharmacist-led interventions may prevent heart disease – WeForNews | Latest News, Blogs
Connect with us

Health

Pharmacist-led interventions may prevent heart disease

Published

on

Heart

London: Researchers have found that pharmacist-led interventions such as patient education, medication review, and medication management can be pivotal in preventing heart-related illnesses.

The study, published in the British Journal of Clinical Pharmacology, support the involvement of pharmacists as healthcare providers in managing patients with hypertension, diabetes and high cholesterol.

“The evidence presented in this review provides an important message to health systems and policymakers regarding the effectiveness of general practice-based pharmacists’ interventions,” said study researcher Abdullah Alshehri from University of Birmingham in the US.

During the finding, the research team assessed medical literature for relevant randomised controlled clinical trials assessing the effectiveness of pharmacist-led interventions delivered in the general practice in reducing the medical risk factors of cardiovascular events.

They identified 21 trials involving a total 8,933 patients.

Pharmacist-led interventions included patient education, medication review and counselling, physical assessment, assessing adherence, lifestyle modification, and medication management such as prescribing, adjusting, monitoring, and administering therapy and identifying drug-related problems.

The most frequently used pharmacist-led interventions were medication review and medication management.

Patients receiving pharmacist-led interventions experienced significant reductions in their systolic blood pressure (by an average of -9.33 mmHg); Hemoglobin A1c, a measure of blood sugar levels (by an average of -0.76%); and LDL-cholesterol (by an average of -15.19 mg/dl).

Pharmacist-led interventions also helped patients correctly follow their prescribed medication regimens.

“The significant reductions in blood pressure, blood glucose, and blood cholesterol reported in this meta-analysis, if sustained in clinical practice, could have significant implications for managing hypertension, diabetes and dyslipidaemia that could prevent cardiovascular morbidity and mortality,” Alshehri said.

Alshehri noted that the findings support a greater involvement of pharmacists in general practice.

“This will benefit health organisations by providing cost-effective care associated with greater control of patients’ conditions and their medications,” he said.

Health

Madras High Court should rule fast on OBC quota in medical seats: Tamil Nadu

A group of petitioners, in their interim prayers in the Madras High Court, attempted to stop the ongoing process of admissions in postgraduate medical courses.

Published

on

By

Madras High Court Chennai

New Delhi, July 2 : The Tamil Nadu government has moved the Supreme Court, seeking a direction to the Madras High Court to “expeditiously hear and dispose” off petitions against the Centre’s decision not granting 50 per cent quota to OBCs in medical seats surrendered by the state in the all India quota in 2020-21.

The state government has challenged the high court’s June 22 order declining any interim order on the OBC quota row. It had adjourned the matter till July 9, citing that a petition similar in nature is scheduled to be taken up for hearing before the apex court on July 8.

The state government had moved the top court on June 11, which asked it to move the high court. “The High Court has erroneously acceded to representations made by the respondents and unjustifiably kept the Petitioner’s writ petition in abeyance till this court issues orders in an ostensibly identical matter in Saloni Kumari v Director General Health Services & Ors which is tentatively listed for July 8,” said the Tamil Nadu government in its plea.

The state government contended that it seeks directions to provide 50 per cent reservation for Backward Classes, most Backward Classes and the Denotified Community in admission to shared seats in postgraduate, undergraduate and diploma medical and dental courses.

Various political parties and the Tamil Nadu government have challenged the Centre’s decision not granting 50 per cent reservation to OBCs as per state law. “Moreover, the High Court has ignored the fact that this court, in an order dated June 11 has, instead of entertaining the petitioner’s petition under Article 32 of the Constitution, expressly granted liberty to the Petitioner to seek relief before the High Court under Article 226,” said the state government plea.

A group of petitioners, in their interim prayers in the Madras High Court, attempted to stop the ongoing process of admissions in postgraduate medical courses.

Reportedly, the Madras High Court had declined to pass any interim order on the petitions after taking on record the Centre’s contention that from 1986, reservation has not been provided in the AIQ (All-India quota) seats for medical admission, which is in accordance with the directive of the top court.

Continue Reading

Disaster

No charges for receiving plasma, Delhi Plasma Bank clarifies

To donate plasma, a donor needs to complete at least 28 days post the treatment of Covid-19. A donor can re-donate plasma after 14 days.

Published

on

By

plasma therapy for COVID-19

New Delhi, July 2 : The Delhi Plasma Bank clarified on Thursday that it does not charge any amount for providing plasma to the patients, after a document started doing the rounds on social media where it was mentioned that the bank would charge Rs 25,000 from private and corporate hospitals against the plasma provided to them.

The Delhi Plasma Bank is the first in the country to store and provide plasma on demand to Covid-19 patients. The bank, inaugurated on Thursday, has been set up at the Institute of Liver and Biliary Sciences (ILBS).

On Thursday evening, a document started getting shared on Twitter and Facebook, which mentioned that the private and corporate hospitals would have to pay Rs 25,000 to receive plasma from the bank.

The document was drafted on the letterhead of the ILBS Hospital and was also uploaded on the website of the hospital. After the upload, it was downloaded and widely shared on Twitter and Facebook. However, it was taken down by the ILBS administration later, stating that it was a “clerical error”.

Shantanu Dubey, in-charge of issuing plasma to the patients, told IANS that the document was an old and unapproved proposal.

“It was a proposal floated a few days ago to the management of the hospital. It did not get approval and was mistakenly uploaded on the hospital”s website on Thursday. However, we have rectified it,” he clarified.

Dubey also said that ILBS is providing plasma free of cost to all. “We are not charging for plasma from anyone. It”s being offered on-demand free of cost,” he added.

Dubey said the bank issued three sets of plasma on Thursday, all to corporate hospitals, without charging any amount. “We provided two B blood group plasma and one from the A blood group,” he informed.

He also informed that six requests of plasma are lined up for Friday. He said the bank has received requests for plasma from across the country, but currently, it will only issue it to the patients in Delhi.

Meanwhile, the bank has directed all the hospitals to appoint nodal officers for making requests for plasma from the bank.

“A few hospitals have appointed nodal officers. The communication regarding issuance and donation will be made only to the nodal officers,” said Rahul Borkar, a resident medical officer in the plasma bank.

The officials at the plasma bank also informed that they will provide travel allowances to the donors coming to the bank to donate their plasma. “We will reimburse up to Rs 1,500 of the travel cost borne by the donor,” Borkar said.

To donate plasma, a donor needs to complete at least 28 days post the treatment of Covid-19. A donor can re-donate plasma after 14 days.

Continue Reading

Disaster

‘US risks greater COVID-19 outbreak if latest surge not controlled’

“Clearly we are not in control right now,” Fauci testified, warning that not enough Americans are wearing masks or social distancing.

Published

on

By

Anthony Fauci

Washington, July 2 : Anthony Fauci, the top US expert in infectious diseases, has expressed his concern over the sudden spike of COVID-19 cases in the country, warning of the risk of a greater outbreak if the latest surge is not controlled.

“We got hit very badly, worse than any country, with regard to the number of cases and the number of deaths,” Fauci told the BBC on Wednesday.

“The problem we”re facing now is that in an attempt to so-called reopen or open the government and get it back to some form of normality, we”re seeing very disturbing spikes in different individual states in the US.

“We”ve got to get that under control or we risk an even greater outbreak in the US,” he added.

As of Thursday, the US accounted for the world”s highest number of infections and fatalities with 2,685,806 and 128,061, respectively, according to the Johns Hopkins University.

Comparing the situation in the US to how some European countries controlled the spread of the virus, Fauci told the BBC: “They closed down to the tune of about 97 per cent lockdown. In the US, even in the most strict lockdown, only about 50 per cent of the country locked down. That allowed the perpetuation of the outbreak.”

“We need to engender some societal responsibility in people, particularly the younger people,” he said, adding that young people were less likely to be seriously affected by COVID-19 but could still spread the disease.

Fauci”s remarks on Wednesday came a day after he told the US Senate that he “would not be surprised” if new virus cases in the country reach 100,000 per day, the BBC reported.

“Clearly we are not in control right now,” Fauci testified, warning that not enough Americans are wearing masks or social distancing.

On Tuesday, cases rose by more than 40,000 in one day for the fourth time in the past five days.

Continue Reading
Advertisement

Most Popular